Basel, November 19, 2024 – Novartis has ranked first in the 2024 Access to Medicine Index (ATMI) report published today, highlighting the company’s leadership in improving access to medicines around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback